Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge.
Saved in:
| Title: | Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. |
|---|---|
| Authors: | Foss S; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway., Jonsson A; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway., Bottermann M; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2-0QH, UK., Watkinson R; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2-0QH, UK., Lode HE; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway., McAdam MB; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway., Michaelsen TE; Department of Chemical Pharmacy, School of Pharmacy, University of Oslo, N-0371 Oslo, Norway.; Infection Immunology, Norwegian Institute of Public Health, N-0213 Oslo, Norway., Sandlie I; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway., James LC; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2-0QH, UK., Andersen JT; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway. |
| Source: | Science immunology [Sci Immunol] 2022 Apr 29; Vol. 7 (70), pp. eabj1640. Date of Electronic Publication: 2022 Apr 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
